These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients. Köker MY, Camcıoğlu Y, van Leeuwen K, Kılıç SŞ, Barlan I, Yılmaz M, Metin A, de Boer M, Avcılar H, Patıroğlu T, Yıldıran A, Yeğin O, Tezcan I, Sanal Ö, Roos D. J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690 [Abstract] [Full Text] [Related]
9. Interpretation of Dihydrorhodamine-1,2,3 Flow Cytometry in Chronic Granulomatous Disease: an Atypical Exemplar. Donko A, Kuhns DB, Cousin MA, Smith MJ, Sacco KA, Klee EW, Joshi AY, Gavrilova RH, Holland SM, Leto TL, Abraham RS. J Clin Immunol; 2022 Jul; 42(5):986-999. PubMed ID: 35344128 [Abstract] [Full Text] [Related]
10. A fast and easy nitroblue tetrazolium method for carrier screening and prenatal detection of chronic granulomatous disease. Ayatollahi M, Tabei Z, Ramzi M, Kashef S, Haghshenas M. Arch Iran Med; 2006 Oct; 9(4):335-8. PubMed ID: 17061605 [Abstract] [Full Text] [Related]
11. Nicotinamide-adenine dinucleotide phosphate oxidase assembly and activation in EBV-transformed B lymphoblastoid cell lines of normal and chronic granulomatous disease patients. Dusi S, Nadalini KA, Donini M, Zentilin L, Wientjes FB, Roos D, Giacca M, Rossi F. J Immunol; 1998 Nov 01; 161(9):4968-74. PubMed ID: 9794433 [Abstract] [Full Text] [Related]
14. NCF1 (p47phox)-deficient chronic granulomatous disease: comprehensive genetic and flow cytometric analysis. Kuhns DB, Hsu AP, Sun D, Lau K, Fink D, Griffith P, Huang DW, Priel DAL, Mendez L, Kreuzburg S, Zerbe CS, De Ravin SS, Malech HL, Holland SM, Wu X, Gallin JI. Blood Adv; 2019 Jan 22; 3(2):136-147. PubMed ID: 30651282 [Abstract] [Full Text] [Related]
15. Nitroblue tetrazolium slide test. Use of the phorbol-myristate-acetate-stimulated NBT-reduction slide test for routine and prenatal detection of chronic granulomatous disease and diagnosis of heterozygous carriers. Johansen KS. Acta Pathol Microbiol Immunol Scand C; 1983 Dec 22; 91(6):349-54. PubMed ID: 6673503 [Abstract] [Full Text] [Related]
16. X-linked chronic granulomatous disease in a male child with an X-CGD carrier, Klinefelter brother. Gill HK, Kumar HC, Cheng CK, Ming CC, Nallusamy R, Yusoff NM, Mohamad SB, Ripen AM, Dhaliwal JS, Murad S. Asian Pac J Allergy Immunol; 2013 Jun 22; 31(2):167-72. PubMed ID: 23859418 [Abstract] [Full Text] [Related]
17. Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions. Emmendörffer A, Nakamura M, Rothe G, Spiekermann K, Lohmann-Matthes ML, Roesler J. Cytometry; 1994 Sep 15; 18(3):147-55. PubMed ID: 7813334 [Abstract] [Full Text] [Related]
18. Focus on FOCIS: the continuing diagnostic challenge of autosomal recessive chronic granulomatous disease. Yu G, Hong DK, Dionis KY, Rae J, Heyworth PG, Curnutte JT, Lewis DB. Clin Immunol; 2008 Aug 15; 128(2):117-26. PubMed ID: 18625437 [Abstract] [Full Text] [Related]
20. Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD. Mauch L, Lun A, O'Gorman MR, Harris JS, Schulze I, Zychlinsky A, Fuchs T, Oelschlägel U, Brenner S, Kutter D, Rösen-Wolff A, Roesler J. Clin Chem; 2007 May 15; 53(5):890-6. PubMed ID: 17384005 [Abstract] [Full Text] [Related] Page: [Next] [New Search]